Atsushi Enomoto
- Nephrology top 0.1%
- Gout, Hyperuricemia, Uric Acid 10
- Oncology top 1%
- Cancer Cells and Metastasis 28
- Drug Transport and Resistance Mechanisms 16
- Clinical Biochemistry top 0.5%
- Metabolism and Genetic Disorders 12
- Molecular Biology top 1%
- Wnt/β-catenin signaling in development and cancer 16
- RNA Research and Splicing 13
- Pharmacology top 0.5%
-
- Cell Adhesion Molecules Research 13
-
- Neurogenesis and neuroplasticity mechanisms 12
Atsushi Enomoto
190 papers receiving 9.7k citations
Hit Papers
Peers
Comparison fields: 5 of 138
- Nephrology 2.6k
- Oncology 2.6k
- Clinical Biochemistry 617
- Molecular Biology 4.1k
- Pharmacology 515
Countries citing papers authored by Atsushi Enomoto
This map shows the geographic impact of Atsushi Enomoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Atsushi Enomoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Atsushi Enomoto more than expected).
Fields of papers citing papers by Atsushi Enomoto
This network shows the impact of papers produced by Atsushi Enomoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Atsushi Enomoto. The network helps show where Atsushi Enomoto may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Atsushi Enomoto, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 6 | |
| 5 | 2024 | 23 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 10 | |
| 9 | 2022 | 10 | |
| 10 | 2022 | 7 | |
| 11 | 2022 | 24 | |
| 12 | 2021 | 5 | |
| 13 | 2021 | 56 | |
| 14 | 2021 | 27 | |
| 15 | 2017 | 42 | |
| 16 | 2015 | 100 | |
| 17 | 2011 | 19 | |
| 18 | 2009 | 53 | |
| 19 | 2008 | 144 | |
| 20 | 2000 | 13 |
About Atsushi Enomoto
Atsushi Enomoto is a scholar working on Developmental Neuroscience, Clinical Biochemistry and Nephrology, having authored 195 papers that have together received 9.9k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (28 papers), Wnt/β-catenin signaling in development and cancer (16 papers), Drug Transport and Resistance Mechanisms (16 papers), Cell Adhesion Molecules Research (13 papers), RNA Research and Splicing (13 papers), Metabolism and Genetic Disorders (12 papers), Neurogenesis and neuroplasticity mechanisms (12 papers) and Gout, Hyperuricemia, Uric Acid (10 papers). The work is most often cited by research in Nephrology (2.6k citations), Oncology (2.6k citations) and Clinical Biochemistry (617 citations). Atsushi Enomoto has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Masahide Takahashi, Hitoshi Endou, Toshimitsu Niwa, Naoya Asai, Michio Takeda, Kimiyoshi Ichida, Yoshiki Murakumo, Ping Jiang, Seok Ho and Makoto Hosoyamada. Their work appears in journals such as Nature, Journal of Biological Chemistry and Journal of Clinical Investigation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.